Advertisement
New insights into atopic dermatitis
Donald Y.M. Leung, Mark Boguniewicz, Michael D. Howell, Ichiro Nomura, and Qutayba A. Hamid
Find articles by Leung, D. in: JCI | PubMed | Google Scholar
Find articles by Boguniewicz, M. in: JCI | PubMed | Google Scholar
Find articles by Howell, M. in: JCI | PubMed | Google Scholar
Find articles by Nomura, I. in: JCI | PubMed | Google Scholar
Find articles by Hamid, Q. in: JCI | PubMed | Google Scholar
Published April 1, 2004 - More info
J Clin Invest. 2004;113(7):1070–1070. https://doi.org/10.1172/JCI21060E1.
© 2004 The American Society for Clinical Investigation
Related article:
Abstract
Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers and is often the first step in the atopic march that results in asthma and allergic rhinitis. The clinical phenotype that characterizes atopic dermatitis is the product of interactions between susceptibility genes, the environment, defective skin barrier function, and immunologic responses. This review summarizes recent progress in our understanding of the pathophysiology of atopic dermatitis and the implications for new management strategies.
Authors
Donald Y.M. Leung, Mark Boguniewicz, Michael D. Howell, Ichiro Nomura, Qutayba A. Hamid
Original citation: J. Clin. Invest.113:651–657 (2003). doi:10.1172/JCI21060.
Citation for this corrigendum: J. Clin. Invest.113:1070 (2004). doi:10.1172/JCI21060E1.
We failed to mention the generous grant support of the Science in Medicine series provided by the Doris Duke Charitable Foundation. We regret the omission.
Copyright © 2024 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)